Search Results - "Golubovskaya, D. P."

A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors by Golubovskaya, D. P., Karetnikova, V. N., Oleinik, I. R., Barbarash, O. L.

“…Heart failure (HF) remains one of the major social and medical public health problems worldwide. Despite new advances in the treatment of patients with HF, the…”
Get full text

Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization by Golubovskaya, D. P., Karetnikova, V. N., Osokina, A. B., Oleinik, I. P., Barbarash, O. L.

“…Aim . Evaluation of the safety, clinical and hemodynamic effects of empagliflozin in patients with acute decompensated heart failure (ADHF) from the first day…”
Get full text

Clinical and anamnestic characteristics of patients depending on left ventricular ejection fraction: results of a register study by Parfenov, P. G., Yurkina, A. V., Golubovskaya, D. P., Shuster, S. Y., Dren, E. V., Guselnikova, Y. I., Lebedeva, N. B., Pecherina, T. B.

“…Aim . To study the clinical and anamnestic features of patients followed up in the Center for Chronic Heart Failure at the Regional Vascular Center according…”
Get full text

Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report by Golubovskaya, D P, Dren', E V, Yurkina, A V, Pecherina, T B, Barbarash, O L

“…Despite the presence of various signs of cardiac amyloidosis ("red flags"), the introduction into routine practice of new non-invasive diagnostic methods…”
Get full text